Cancer News and Research

Latest Cancer News and Research

Complete Genomics, SAIC-Frederick collaborate to validate somatic mutations from pediatric cancer cases

Complete Genomics Inc., a life sciences company focused on human genome sequencing, today announced a collaboration to identify and validate somatic mutations from 50 pediatric cancer cases from multiple research centers across the United States.

7 Sep 2010

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

7 Sep 2010

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.

7 Sep 2010

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.

7 Sep 2010

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

Tiger Balm announced today its sponsorship of the 20th annual Susan G. Komen NYC Race for the Cure, taking place Sunday, September 12, 2010 in New York's Central Park.

7 Sep 2010

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

7 Sep 2010

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.

7 Sep 2010

Popularity of e cigarettes increase despite FDA's stance

Electronic cigarette sales and popularity continues to increase on a daily basis despite the US Food and Drug Administration's attempts to label the products as unsafe and untested for their intended purpose. Thousands of electronic cigarette reviews online dispute the stance of the FDA, many of them stating that the products have not only been tested, but by and large have been found to be less harmful than traditional cigarettes.

7 Sep 2010

RA synthetic derivative 4-HPR's ability to induce tumour cell death

Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.

7 Sep 2010

NHS Choices unveils typical signs, symptoms of cancer

More than 1/3 people in the UK will develop some form of cancer during their lifetime.The good news is that some cancers can be cured if detected early enough. The key is to be aware of unexplained changes to your body, and to know the common signs and symptoms of cancer.

7 Sep 2010

Swarovski's '22 Ways To Say Black' auction proceeds to benefit cancer charities

SWAROVSKI ELEMENTS has commissioned 22 of fashion's most notable known names and talented newcomers to design one-of-a-kind little black dresses for the initiative 22 Ways To Say Black. On September 20, 2010 at the acclaimed gallery, Phillips de Pury & Company in New York City, under the high-patronage of Carla Bruni-Sarkozy, the one-of-a-kind dresses will be auctioned off by Simon de Pury, with 100% of the proceeds to benefit the American Cancer Society and La ligue nationale contre le cancer in France.

7 Sep 2010

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

A pilot study suggests the hallucinogen psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Sep 2010

Research suggests blocking HMGB1 protein can benefit cancer patients

Like some people, cells eat when they are under pressure-but they consume parts of themselves. A multi-function protein helps control this form of cannibalism, according to a study in the September 6 issue of the Journal of Cell Biology.

7 Sep 2010

Axelar AB publishes first AXL1717 data on phase I/II cancer study

Axelar AB today announces that the first submitted medical article on the ongoing phase I/II cancer study with AXL1717 has been published in Acta Oncologica.

7 Sep 2010

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online today in the Archives of General Psychiatry.

7 Sep 2010

Protagen AG announces € 10.0 Million for second round of finance totaling

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis announced today a second round of finance totalling a volume of € 10.0 Million.

7 Sep 2010

Researchers to develop new treatment strategy for cancer

Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough.

7 Sep 2010

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures published by Cancer Research UK today.

7 Sep 2010

Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.

6 Sep 2010

Gene containing 'minisatellite' plays key role in driving human DNA diversity

One of the key drivers of human evolution and diversity, accounting for changes that occur between different generations of people, is explained by new research published today (Sept 5) by world-renowned scientist Professor Sir Alec Jeffreys, who discovered DNA fingerprinting at the University of Leicester.

6 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Complete Genomics, SAIC-Frederick collaborate to validate somatic mutations from pediatric cancer cases

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

Popularity of e cigarettes increase despite FDA's stance

RA synthetic derivative 4-HPR's ability to induce tumour cell death

NHS Choices unveils typical signs, symptoms of cancer

Swarovski's '22 Ways To Say Black' auction proceeds to benefit cancer charities

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

Research suggests blocking HMGB1 protein can benefit cancer patients

Axelar AB publishes first AXL1717 data on phase I/II cancer study

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

Protagen AG announces € 10.0 Million for second round of finance totaling

Researchers to develop new treatment strategy for cancer

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA

Gene containing 'minisatellite' plays key role in driving human DNA diversity

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in